Article
Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content.
Scientific reports - 27 Nov 2019
Tonin Rodolfo, Caciotti Anna, Procopio Elena, Fischetto Rita, Deodato Federica, Mancardi Maria Margherita, Di Rocco Maja, Ardissone Anna, Salviati Alessandro, Marangi Antonio, Strisciuglio Pietro, Mangone Giusi, Casini Arianna, Ricci Silvia, Fiumara Agata, Parini Rossella, Pavone Francesco Saverio, Guerrini Renzo, Calamai Martino, Morrone Amelia
Abstract excerpt
GM1 ganglioside, a monosialic glycosphingolipid and a crucial component of plasma membranes, accumulates in lysosomal storage disorders, primarily in GM1 gangliosidosis. The development of biomarkers for simplifying diagnosis, monitoring disease progression and evaluating drug therapies is an important objective in research into neurodegenerative lysosomal disorders. With this in mind, we established fluorescent...
Topics
- 1-Deoxynojirimycin
- Biomarkers
- Cells, Cultured
- Disease Progression
- Female
- Fibroblasts
- Flow Cytometry
- G(M1) Ganglioside
- Gangliosidosis, GM1
